Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Research Article

Fetal Cardiac Cellular Damage Caused by Anemia in Utero in Hb Bart’s Disease

Author(s): Phudit Jatavan, Sirinart Kumfu, Theera Tongsong* and Nipon Chattipakorn*

Volume 21, Issue 2, 2021

Published on: 10 June, 2020

Page: [165 - 175] Pages: 11

DOI: 10.2174/1566524020666200610163546

Price: $65

Abstract

Background: Severe fetal anemias can cause high output cardiac failure. Mitochondria are key regulators of cardiac function. However, the effects of an early phase of fetal anemia on the fetal heart and cardiac mitochondrial function are not known.

Objective: The aim of this study is to compare mitochondrial function and cardiac biochemical alterations in the fetal cardiac tissue between anemic and non-anemic fetuses.

Materials and Methods: A cross-sectional study was conducted in Fetuses affected by Hb Bart’s disease (n=18) and non-anemic fetuses (n=10) at 17-20 weeks. Echocardiograms had been carried out in all cases to assess prenatal cardiac function. Cardiac tissues were collected after pregnancy termination for the determination of cardiac iron accumulation, mitochondrial function, including mitochondrial ROS production, mitochondrial depolarization and mitochondrial swelling, mitochondrial dynamics, inflammation, and apoptosis.

Results: Prenatal cardiac function evaluated by ultrasound was comparable between the Hb Bart’s and non-anemic groups. In Bart’s group, the levels of cardiac mitochondrial depolarization and swelling, and the TNF-α level were significantly higher, compared to the non-anemic group. On the contrary, anti-inflammatory (IL-10) levels were significantly lower in the Hb Bart’s group. Additionally, active caspase-3 and Bcl-2 expression were also significantly higher (P= 0.001, P=0.035) in Bart’s group. The mitochondrial fission protein expression, including p-DRP1/total DRP1, was significantly higher in Bart’s group. However, there was no difference in cardiac iron accumulation levels between these two groups.

Conclusion: Despite equivalent prenatal cardiac function and comparable cardiac iron accumulation in the Bart’s and non-anemic groups, fetal anemia is significantly associated with cardiac mitochondrial dysfunction, increased mitochondrial fission, and increased inflammation and apoptosis. These findings indicate that an early phase of fetal anemia without cardiac iron overload can lead to cardiac mitochondrial dysfunction in fetuses with Hb Bart’s.

Keywords: Anemia, apoptosis, cardiac tissue, cardiac function, fetus, hemoglobin, Bart's disease, mitochondrial function, oxidative stress.

« Previous Next »
[1]
Meriki N, Welsh AW. Technical considerations for measurement of the fetal left modified myocardial performance index. Fetal Diagn Ther 2012; 31(1): 76-80.
[http://dx.doi.org/10.1159/000334385] [PMID: 22236694]
[2]
Sikkel E, Klumper FJ, Oepkes D, et al. Fetal cardiac contractility before and after intrauterine transfusion. Ultrasound Obstet Gynecol 2005; 26(6): 611-7.
[http://dx.doi.org/10.1002/uog.1996] [PMID: 16254879]
[3]
Kumfu S, Chattipakorn SC, Fucharoen S, Chattipakorn N. Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice. Exp Physiol 2016; 101(4): 521-39.
[http://dx.doi.org/10.1113/EP085517] [PMID: 26824522]
[4]
Kumfu S, Chattipakorn S, Fucharoen S, Chattipakorn N. Mitochondrial calcium uniporter blocker prevents cardiac mitochondrial dysfunction induced by iron overload in thalassemic mice Biometals: an international journal on the role of metal ions in biology, biochemistry, and medicine 2012; 25(6): 1167-75.
[http://dx.doi.org/10.1007/s10534-012-9579-x]
[5]
Thummasorn S, Kumfu S, Chattipakorn S, Chattipakorn N. Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria. Mitochondrion 2011; 11(3): 457-66.
[http://dx.doi.org/10.1016/j.mito.2011.01.008] [PMID: 21292035]
[6]
Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PP, Backx PH. Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ Res 1999; 84(11): 1302-9.
[http://dx.doi.org/10.1161/01.RES.84.11.1302] [PMID: 10364568]
[7]
Kumfu S, Chattipakorn S, Fucharoen S, Chattipakorn N. Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels. Drug Chem Toxicol 2013; 36(3): 329-34.
[http://dx.doi.org/10.3109/01480545.2012.726625] [PMID: 23050671]
[8]
Chua AC, Graham RM, Trinder D, Olynyk JK. The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci 2007; 44(5-6): 413-59.
[http://dx.doi.org/10.1080/10408360701428257] [PMID: 17943492]
[9]
Oudit GY, Sun H, Trivieri MG, et al. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003; 9(9): 1187-94.
[http://dx.doi.org/10.1038/nm920] [PMID: 12937413]
[10]
Wallander ML, Leibold EA, Eisenstein RS. Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim Biophys Acta 2006; 1763(7): 668-89.
[http://dx.doi.org/10.1016/j.bbamcr.2006.05.004] [PMID: 16872694]
[11]
Silva FH, Veiga FJR, Mora AG, et al. A novel experimental model of erectile dysfunction in rats with heart failure using volume overload. PLoS One 2017; 12(11)e0187083
[http://dx.doi.org/10.1371/journal.pone.0187083] [PMID: 29095897]
[12]
Pervaiz S. Redox pioneer: professor Barry Halliwell. Antioxid Redox Signal 2011; 14(9): 1761-6.
[http://dx.doi.org/10.1089/ars.2010.3518] [PMID: 20969479]
[13]
Matsushima S, Kinugawa S, Ide T, et al. Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart. Am J Physiol Heart Circ Physiol 2006; 291(5): H2237-45.
[http://dx.doi.org/10.1152/ajpheart.00427.2006] [PMID: 16844917]
[14]
Shiomi T, Tsutsui H, Matsusaka H, et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2004; 109(4): 544-9.
[http://dx.doi.org/10.1161/01.CIR.0000109701.77059.E9] [PMID: 14744974]
[15]
Zhou B, Tian R. Mitochondrial dysfunction in pathophysiology of heart failure. J Clin Invest 2018; 128(9): 3716-26.
[http://dx.doi.org/10.1172/JCI120849] [PMID: 30124471]
[16]
Kiyuna LA, Albuquerque RPE, Chen CH, Mochly-Rosen D, Ferreira JCB. Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities. Free Radic Biol Med 2018; 129: 155-68.
[http://dx.doi.org/10.1016/j.freeradbiomed.2018.09.019] [PMID: 30227272]
[17]
Dietl A, Maack C. Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure. Curr Heart Fail Rep 2017; 14(4): 338-49.
[http://dx.doi.org/10.1007/s11897-017-0347-7] [PMID: 28656516]
[18]
Münzel T, Camici GG, Maack C, Bonetti NR, Fuster V, Kovacic JC. Impact of Oxidative Stress on the Heart and Vasculature: Part 2 of a 3-Part Series. J Am Coll Cardiol 2017; 70(2): 212-29.
[http://dx.doi.org/10.1016/j.jacc.2017.05.035] [PMID: 28683969]
[19]
Niemann B, Rohrbach S, Miller MR, Newby DE, Fuster V, Kovacic JC. Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series. J Am Coll Cardiol 2017; 70(2): 230-51.
[http://dx.doi.org/10.1016/j.jacc.2017.05.043] [PMID: 28683970]
[20]
Lian WS, Lin H, Cheng WT, Kikuchi T, Cheng CF. Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy. J Biomed Sci 2011; 18: 26.
[http://dx.doi.org/10.1186/1423-0127-18-26] [PMID: 21496220]
[21]
Mariappan N, Elks CM, Fink B, Francis J. TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction. Free Radic Biol Med 2009; 46(4): 462-70.
[http://dx.doi.org/10.1016/j.freeradbiomed.2008.10.049] [PMID: 19041937]
[22]
Liesa M, Palacín M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 2009; 89(3): 799-845.
[http://dx.doi.org/10.1152/physrev.00030.2008] [PMID: 19584314]
[23]
Chen H, Chan DC. Physiological functions of mitochondrial fusion. Ann N Y Acad Sci 2010; 1201: 21-5.
[http://dx.doi.org/10.1111/j.1749-6632.2010.05615.x] [PMID: 20649534]
[24]
Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 2007; 8(11): 870-9.
[http://dx.doi.org/10.1038/nrm2275] [PMID: 17928812]
[25]
Palaniyandi SS, Qi X, Yogalingam G, Ferreira JC, Mochly-Rosen D. Regulation of mitochondrial processes: a target for heart failure. Drug Discov Today Dis Mech 2010; 7(2): e95-e102.
[http://dx.doi.org/10.1016/j.ddmec.2010.07.002] [PMID: 21278905]
[26]
Pennanen C, Parra V, López-Crisosto C, et al. Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway. J Cell Sci 2014; 127(Pt 12): 2659-71.
[http://dx.doi.org/10.1242/jcs.139394] [PMID: 24777478]

Rights & Permissions Print Cite
Article Metrics
22
1
World Malaria Day
© 2024 Bentham Science Publishers | Privacy Policy